Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study

Exclusion Criteria

• •Administration of iohexol the week before intensive care admission
• •Administration of iohexol expected within 24 hours of study entry
• •Known history of cutaneous immediate or delayed allergic reaction to the injection of the product
• •Indication for albumin transfusion within 24 hours of potential inclusion in the study
• •Pregnancy or breastfeeding in progress
• •Patient under guardianship or judicial protection known at the time of inclusion
• •Withdrawal of consent
• •Administration of iohexol outside the study within 24 hours after administration of iohexol in the context of the study
• •Administration of intravenous albumin in the 24 hours following administration of iohexol in the context of the study